Gerd Stötter studied biochemistry with focus on immunology, protein chemistry and neuroscience in Berlin and Montpellier (France).
After completing his studies, he worked in the laboratory of Ton Schumacher at the Dutch Cancer Institute in Amsterdam in the field of immunology and in the laboratory of Amadeo Caflisch at the University of Zurich in computer-aided drug design.
Since 2002 Gerd has been working in the field of intellectual property – since 2005 as a partner of the patent law firm Kailuweit & Uhlemann. He is a European Patent Attorney since 2008.
Since 2017 Gerd has been head of the Dresden working group of the Chamber of Patent Attorneys. He is the author of articles concerning the patenting of biotechnological inventions and regularly gives lectures and seminars in this field.
Gerd represents the interests of his clients before the German Patent and Trademark Office, the Federal Patent Court, the European Patent Office, the Office of the European Union for Intellectual Property (EUIPO) and the WIPO and also assists in the enforcement or defence of rights before ordinary courts. He is also admitted as a representative before the Unified Patent Court (UPC).
His practice focuses on patent and utility model law (particularly in the fields of biotechnology and pharmaceuticals as well as materials technology), trademark law, design law, licensing law, infringement proceedings and employee invention law.
He is a member of GRUR (German Association for the Protection of Intellectual Property), the VPP (Association of Intellectual Property Experts), the Federal Association of Patent Attorneys and the Saxon Patent Attorney Association.
His working languages are German, English and French.